Skip to content

Whole Body Vibration Therapy in Individuals With Type 2 Diabetes

The Effect of Whole Body Vibration Therapy on Muscle Oxygenation in Individuals With Type 2 Diabetes: A Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07002125
Enrollment
20
Registered
2025-06-03
Start date
2025-08-01
Completion date
2025-12-31
Last updated
2025-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aerobic Exercise, Muscle Oxygenation, Type 2 Diabetes, Whole Body Vibration

Keywords

Aerobic exercise, diapason, balance, HbA1c, type 2 diabetes, whole body vibration, muscle oxygenation

Brief summary

The aim of this interventional study is to investigate the effect of whole body vibration therapy on muscle oxygenation, vibration sensation, functional capacity and balance in individuals with Type 2 diabetes. The main questions aimed to be answered are: * Does whole body vibration therapy affect peripheral muscle oxygenation? * Does whole body vibration therapy improve vibration sense, functional capacity and balance compared to aerobic exercise? Participants' muscle oxygenation, vibration sensation, functional capacity and balance parameters will be assessed. They will participate in a whole body vibration therapy or aerobic training program.

Interventions

OTHERWhole Body Vibration

Each exercise session will be performed with a frequency of 30 Hz and an amplitude of 2 mm. Participants are in a 110° squat position on the platform (the degree will be adjusted using a goniometer). Participants will exercise for 16 minutes from week one to week three, 20 minutes from week four to week six and 24 minutes from week seven to week eight, respectively (8 iterations and 1 minute of vibration with 1 minute interval between each iteration)

OTHERAerobic Exercise

From week one to week three, from week four to week six and from week seven to week eight, the participants will exercise for 30 minutes (5 minutes of running at 60-70% of heart rate and 5 minutes of active rest at 30-45% of maximum heart rate), 42 minutes (7 minutes of running at 60-70% of heart rate and 7 minutes of active rest at 30-45% of maximum heart rate) and 60 minutes (10 minutes of running at 60-70% of heart rate and 10 minutes of active rest at 30-45% of maximum heart rate). The exercise sessions consist of warm-up, main program and cool-down phases.

Sponsors

Gazi University
CollaboratorOTHER
Ankara Medipol University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The study is planned as a triple-blind, randomized controlled trial. Patients will not be informed about their group. The assessment will be followed by 1 physiotherapist, and the exercise program will be followed by 2 physiotherapists (the physiotherapist performing the assessment is not included). Study groups will be coded before statistical analysis, and the meaning of the codes will not be told to the statistician.

Intervention model description

Individuals with Type 2 diabetes who agreed to participate in the study will be divided into two groups as aerobic exercise group (AE) and whole body vibration group (AE+WBV).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Volunteering to participate in the research * Being diagnosed with type 2 diabetes * 18 years of age or older * HbA1c level to be 6.5-10% * Having a clinical history of diabetes between 2-10 years * Receiving oral hypoglycemic agent treatment * At least three HbA1c measurements within 12 to 24 months * Hemoglobin variability score (HVS) \<50 * Being able to walk independently * Mini mental test score ≥ 24 * Vastus lateralis muscle adipose tissue thickness \<20mm * BMI \<30 kg/m2

Exclusion criteria

* Previous or concurrent psychiatric, neurological, orthopedic or systemic illness * Use of insulin in treatment * Diabetic neuropathy * Foot ulcer * Participation in any exercise program in the last 6 months * History of major hypoglycemia in the last 12 months * Working or have worked in a job with high exposure to mechanical whole body vibrations * Conditions that may contraindicate whole body vibration (deep vein thrombosis, severe osteoporosis, active cancer, implanted medical devices, etc.) * Hearing, vision and perception problems that may affect research results

Design outcomes

Primary

MeasureTime frameDescription
Muscle Oxygenation8 weeksVastus lateralis muscle oxygenation will be evaluated with Near-Infrared Spectroscopy at rest, during and after the 6-Minute Walk Test (6MWT)

Secondary

MeasureTime frameDescription
Vibration sense8 weeksThe sense of vibration will be assessed with a 128 Hz diapason. The lower end of the device will be brought into contact with the plantar surface of the first metatarsal bone, the medial malleolus, and the medial tuberosity of the tuberositas tibia in both lower extremities of the individual. The moment the diapozone touches the tested areas will be considered as the zero-second (0th second, start), and the test will be terminated when the individual perceives that the vibration disappears completely and the time will be recorded in seconds. Three trials will be performed on the areas in both lower extremities, and the average will be reported.
The Timed Up & Go Test8 weeksIt is a measurement that evaluates functional mobility, dynamic balance, fall risk and postural stability that can be applied for different purposes in different age and patient groups. The activities that make up the test evaluate the transition from sitting to standing position, walking, turning, and sitting again, which are necessary for functional mobility and dynamic balance. The TUG test measures the time it takes for an individual to get up from a standard chair with armrests and walk a distance of 3 meters, return from a designated or marked place, return to the chair, and sit back down.
The 6 minute walk test8 weeksThe individual is asked to walk on a certain track for 6 minutes. The test is performed in a closed area, on a flat surface of 30 m in length and under the supervision of the evaluator. After six minutes, the total distance walked is recorded in meters.
The 30-second Chair Stand Test8 weeksIn a chair with a sitting height of 43.2 cm and a back supported, the patient is asked to sit and stand as quickly as possible. The patient sits in the chair. They cross their hands on their chest. Before the test, 2 attempts are made. The number of sitting down times is noted by keeping a 30-second timer with a stopwatch. Less than 10 sit-ups in 30 seconds indicates lower extremity muscle weakness.
Balance8 weeksBalance assessment will be performed with the Biodex Balance System (Biodex Medical Systems Inc., Shirley, NY, USA). The static balance test (eyes open-closed) test, which measures the angular movement of the center of gravity, will be used in the study.

Countries

Turkey (Türkiye)

Contacts

Primary ContactSelcan Suicmez, Research Asst.
selcansuicmez@hotmail.com+90 312 444 20 10
Backup ContactZeynep Hazar, Prof. Dr.
zhazar@gazi.edu.tr+90 312 216 26 21

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026